Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cytogenet Cell Genet ; 74(1-2): 99-101, 1996.
Article in English | MEDLINE | ID: mdl-8893811

ABSTRACT

Prolyl oligopeptidase is a large monomeric proline specific serine endopeptidase, the activity of which correlates well with different stages of depression. We have subregionally mapped human lymphocytic prolyl oligopeptidase (PREP) by FISH using a cosmid probe. The probe mapped to the long arm of chromosome 6, and the signal clustered in band q22.


Subject(s)
Chromosome Mapping , Chromosomes, Human, Pair 6 , Serine Endopeptidases/genetics , Cosmids , Humans , In Situ Hybridization, Fluorescence , Lymphocytes/enzymology , Lymphocytes/ultrastructure , Polymerase Chain Reaction , Prolyl Oligopeptidases
2.
J Leukoc Biol ; 58(3): 325-30, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7665988

ABSTRACT

It was previously shown that CD26 (DPP IV, EC 3.4.14.5) is a binding site for adenosine deaminase (ADA, EC 3.5.4.4) on T cells and that costimulation by some anti-CD26 monoclonal antibodies (mAbs) and anti-CD3 induces CD4+ T cell proliferation. The CD26 epitopes involved in costimulation, the precise sequence of the events preceding proliferation, and the response of CD8+ compared with CD4+ T cells to CD26 were not extensively studied. We therefore compared the effects of the novel TA5.9 anti-CD26 mAb, recognizing an ADA-binding epitope, and the clearly distinct anti-Ta1 reference anti-CD26 mAb for their costimulatory properties in various T cell subsets. Both purified CD4+ and CD8+ T cells proliferated upon costimulation with anti-CD3 and either anti-CD26 mAb, but anti-TA5.9 mAb induced a more potent response than anti-Ta1. Either anti-CD26 mAb, together with anti-CD3, caused a similar sequential up-regulation of CD69, CD25 (IL-2R alpha), and CD71 (transferrin receptor) expression on CD4+ and CD8+ T cells. The activation markers appeared faster on the CD45R0+ than on the CD45R0- subsets. After costimulation, CD4+ T cell cultures contained significant amounts of the Th1 cytokines IL-2, interferon-gamma (IFN-gamma), and tumor necrosis factor-alpha (TNF-alpha). In CD8+ T cell cultures relatively more IFN-gamma and TNF-alpha but almost no IL-2 was measured after triggering of CD3 and CD26. Our data demonstrate that the recognition of the ADA-binding epitope is not a prerequisite for the costimulatory capacity of anti-CD26 mAbs. Both CD4+ and CD8+ T cells and their CD45R0- and CD45R0+ subsets are sensitive to various aspects of activation via CD26, but the magnitude and/or kinetics differ according to the anti-CD26 used and the T cell subset studied.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Dipeptidyl Peptidase 4/immunology , Lymphocyte Activation , Adenosine Deaminase/metabolism , CD3 Complex/physiology , Humans , In Vitro Techniques , Interferon-gamma/biosynthesis , Interleukin-2/biosynthesis , Interleukin-5/biosynthesis , Signal Transduction , Time Factors , Tumor Necrosis Factor-alpha/biosynthesis
3.
Clin Chim Acta ; 195(3): 125-31, 1991 Jan 15.
Article in English | MEDLINE | ID: mdl-1674236

ABSTRACT

The determination in human platelets of four exopeptidases--aminopeptidase P, dipeptidyl peptidase IV, carboxypeptidase N, and angiotensin converting enzyme--by means of fluorometric or liquid chromatography techniques was carried out. The results obtained show that the specific activities of dipeptidyl peptidase IV, carboxypeptidase N, and angiotensin converting enzyme in intact and disrupted platelets are small compared to their specific activities in serum. However, for aminopeptidase P the specific activity of this enzyme is much higher in platelets than in serum. This suggests that circulating platelets may have a significant role as scavengers for circulating peptides containing bonds susceptible for aminopeptidase P.


Subject(s)
Aminopeptidases/blood , Blood Platelets/enzymology , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/blood , Lysine Carboxypeptidase/blood , Peptidyl-Dipeptidase A/blood , Dipeptidyl Peptidase 4 , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...